1Q38

Anastellin


Experimental Data Snapshot

  • Method: SOLUTION NMR
  • Conformers Calculated: 100 
  • Conformers Submitted: 35 
  • Selection Criteria: structures with the lowest energy 

wwPDB Validation   3D Report Full Report


This is version 1.2 of the entry. See complete history


Literature

Anastellin, an FN3 fragment with fibronectin polymerization activity, resembles amyloid fibril precursors

Briknarova, K.Akerman, M.E.Hoyt, D.W.Ruoslahti, E.Ely, K.R.

(2003) J Mol Biol 332: 205-215

  • DOI: 10.1016/s0022-2836(03)00890-8
  • Primary Citation of Related Structures:  
    1Q38

  • PubMed Abstract: 
  • Anastellin is a carboxy-terminal fragment of the first FN3 domain from human fibronectin. It is capable of polymerizing fibronectin in vitro, and it displays anti-tumor, anti-metastatic and anti-angiogenic properties in vivo. We have determined the s ...

    Anastellin is a carboxy-terminal fragment of the first FN3 domain from human fibronectin. It is capable of polymerizing fibronectin in vitro, and it displays anti-tumor, anti-metastatic and anti-angiogenic properties in vivo. We have determined the structure of anastellin using nuclear magnetic resonance spectroscopy and identified residues critical for its activity. Anastellin exhibits dynamic fluctuations and conformational exchange in solution. Its overall topology is very similar to the corresponding region of full-length FN3 domains. However, its hydrophobic core becomes solvent-accessible and some of its beta-strands lose their protection against hydrogen bonding to beta-strands from other molecules. These features seem to be relevant for the fibronectin polymerization activity of anastellin and resemble the characteristics of amyloid fibril precursors. We suggest that this analogy is not random and may reflect similarities between fibronectin and amyloid fibril formation.


    Related Citations: 
    • Superfibronectin is a functionally distinct form of fibronectin
      Morla, A., Zhang, Z., Ruoslahti, E.
      (1994) Nature 367: 193
    • A polymeric form of fibronectin has antimetastatic effects against multiple tumor types
      Pasqualini, R., Bourdoulous, S., Koivunen, E., Woods Jr., V.L., Ruoslahti, E.
      (1996) Nat Med 2: 1197
    • A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis
      Yi, M., Ruoslahti, E.
      (2001) Proc Natl Acad Sci U S A 98: 620

    Organizational Affiliation

    The Burnham Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037-1062, USA.



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
FibronectinA89Homo sapiensMutation(s): 0 
Gene Names: FN1 OR FNFN1FN
Find proteins for P02751 (Homo sapiens)
Explore P02751 
Go to UniProtKB:  P02751
NIH Common Fund Data Resources
PHAROS  P02751
Protein Feature View
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: SOLUTION NMR
  • Conformers Calculated: 100 
  • Conformers Submitted: 35 
  • Selection Criteria: structures with the lowest energy 
  • OLDERADO: 1Q38 Olderado

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2003-11-04
    Type: Initial release
  • Version 1.1: 2008-04-29
    Changes: Version format compliance
  • Version 1.2: 2011-07-13
    Changes: Version format compliance